SPOT - Light检测可计算出一个乳腺癌样本中存在多少her 2基因;这种基因越多,用赫赛汀治疗肿瘤就越有效。
The SPOT-Light test can measure how many HER2 genes are present in a sample of breast tumor; the more genes there are, the more likely the tumor will respond to treatment with Herceptin.
目的:探讨用ATP生物荧光肿瘤体外药敏检测技术(ATP-TCA)研究乳腺癌药物敏感性的异质性以及个体化治疗的可行性。
Objective:To investigate the heterogeneity of chemosensitivity in breast cancer using an ATP-tumor chemosensitivity assay (ATP-TCA) and the feasibility of individual chemotherapy.
目的探讨CA15 - 3、CA125、CEA 3项肿瘤标志物联合检测对乳腺癌早期诊断和鉴别诊断的意义。
Objective It is to discuss the significance of CA15-3, CA125 and CEA combined detected on early diagnosis and differential diagnosis of breast cancer.
应用推荐